Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

Basal/bolus regimens have been shown to result in lower fasting blood glucose levels with less nocturnal hypoglycemia than regimens that use intermediate-acting NPH insulin in children/adolescents ...

Inhaled insulin is effective for controlling blood sugar levels in children with diabetes, providing them with a ...

Once-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes — Insulin efsitora may potentially change the management paradigm, researcher says ...

Across the three trials, efsitora demonstrated an overall safety profile comparable to two of the most commonly used daily basal insulin therapies for type 2 diabetes.

However few trials have used basal insulin analogues as the basal insulin in the MDI group and individuals with established SH have often been excluded from prospective studies.

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found. In QWINT-1, there was a similar ...

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. The Danish drugmaker has reported the ...

FDA rejects Novo Nordisk’s once-weekly basal insulin for people with diabetes, which would reduce the number of injections needed.

DiabetesMine explores how long a person with diabetes can live without insulin and how they can prolong life.